Alert detail
FDA Approval: YERVOY (IPILIMUMAB) — Type 1 - New Molecular Entity
Policy ID: FDA-BLA125377Specialty: OncologyAdded: 6/17/2026Effective: 2011-03-25billing update
Full alert analysis requires a subscription
Subscribe to access the complete alert summary, AI-generated action recommendations, source document links, LCD revision comparisons, and related alerts.